University Medical Centre Ljubljana
Ljubljana, Osrednjaslovenska, 1000, Slovenia
NCT Number: NCT07446244
The purpose of this study is to evaluate feasibility, safety, and efficacy of pulmonary vein isolation combined with posterior left atrial isolation and multiple linear lesions in both atria in patients with persistent and long-standing persistent atrial fibrillation.
Interested in participating?
Request InfoUp to 80 year
All sexes
Interventional
Not applicable
Ljubljana, Osrednjaslovenska, 1000, Slovenia
Patients with long-standing and persistent atrial fibrillation with severely dilated left atrium will undergo pulmonary vein isolation, box-lesion set of posterior wall, lateral mitral line (Marshall vein ablation and coronary sinus ablation per operator's discretion, anterior line, cavotricuspid line, superior caval vein isolation, intercaval line and inferior septal line. Ablations will be performed with either radiofrequency energy or pulsed field ablation at operator's discretion. Block at each line will be checked at the end of the procedure. The procedure will be performed with compliance of producer recommendation and hospital protocol.
All patients will be invited back at three months after index procedure for an invasive remap. At the remap procedure, pulmonary veins and posterior wall will be checked for isolation and all the additional lines will be checked for conduction block. Any gaps in lines will be ablated per operator's discretion.
Patients will undergo a period follow-up visit at 3, 6, and 12-month period. They will undergo a medical history taking, physical examination, ECG, and 7-day Holter ECG. Any documented atrial arrhythmia lasting more than 30 seconds after 8 week blanking period will be documented as a recurrence of atrial fibrillation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Endovascular pulmonary vein isolation, posterior left atrial isolation and multiple linear lesions in both atria using electroporation and radiofrequency energy.
Time frame: 12 months
Atrial fibrillation/atrial tachycardia/atrial undulation lasting more than 30s after 8 week blanking period and without antiarrhythmic drug therapy. Assessed with 7-day Holter ECG at 3, 6, 12 months after index procedure.
Time frame: 12 month
Atrial fibrillation burden will be assessed with 7-day Holter ECG at 3, 6 and 12 months post procedure.
Time frame: 12 months
Initiations of antiarrhythmic drug therapy, number of cardioversions, number of repeat procedures after index procedure will be assessed.
Time frame: 3 months
Number of durable blocks across ablation lines and durable isolations (pulmonary veins, superior vena cava) on invasive remap at 3 months will be assessed.
Time frame: 6 months
Incidence of adverse events defined as events, which require prolonged hospitalization, additional intervention or permanent damage to patients health or cause death in a 180 day period after catheter ablation.
University Medical Centre Ljubljana
Other
Acronym: ENDO MAZE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05988411
Arrhythmias, Cardiac, Atrial Fibrillation
Jonesboro, Arkansas, United States
View Trial DetailsNCT07575269
Arrhythmias, Cardiac, Atrial Fibrillation
Jonesboro, Arkansas, United States
View Trial DetailsNCT06096337
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, Alabama, United States
View Trial DetailsNCT06510556
Arrhythmias, Cardiac, Atrial Fibrillation
Brussels, Belgium
View Trial Details